BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 445508)

  • 1. Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.
    Hayes FA; Green AA; Senzer N; Pratt CB
    Cancer Treat Rep; 1979 Apr; 63(4):547-8. PubMed ID: 445508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of advanced neuroblastoma with regimens containing cis-dichlorodiammineplatinum--effect and toxicity].
    Bessho F; Mizutani S; Kinumaki H; Kaku H; Nakamura K; Inaba T; Tsuchida Y; Yokota S; Kobayashi N
    Gan To Kagaku Ryoho; 1984 May; 11(5):1116-21. PubMed ID: 6539099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetany associated with cis-platin.
    Stuart-Harris R; Ponder BA; Wrigley PF
    Lancet; 1980 Dec; 2(8207):1303. PubMed ID: 6108477
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetany in children treated with cisplatinum.
    Welch RJ; Pearson AD; Craft AW
    Pediatr Hematol Oncol; 1987; 4(2):167-70. PubMed ID: 3152923
    [No Abstract]   [Full Text] [Related]  

  • 6. Tetany as a Delayed Manifestation of Cisplatin Toxicity.
    Premraj S; Nikita M; Rajasekaran D
    J Assoc Physicians India; 2017 Aug; 65(8):115. PubMed ID: 28799322
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
    Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
    Von Hoff DD; Schilsky R; Reichert CM; Reddick RL; Rozencweig M; Young RC; Muggia FM
    Cancer Treat Rep; 1979; 63(9-10):1527-31. PubMed ID: 387223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological study of latent hypomagnesemia tetany in children].
    Poenaru S; Stefánică-Motoc L
    Electromyography; 1969; 9(2):131-66. PubMed ID: 5381960
    [No Abstract]   [Full Text] [Related]  

  • 11. Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study.
    Nitschke R; Fagundo R; Berry DH; Falletta JM
    Cancer Treat Rep; 1979 Mar; 63(3):497-9. PubMed ID: 427829
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.
    Hayes FA; Green AA; Casper J; Cornet J; Evans WE
    Cancer; 1981 Oct; 48(8):1715-8. PubMed ID: 7197189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-induced hypocalcemia and hypomagnesemia.
    Lyman NW; Hemalatha C; Viscuso RL; Jacobs MG
    Arch Intern Med; 1980 Nov; 140(11):1513-4. PubMed ID: 7192079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
    Quasdorff M; Mertens J; Dinter J; Steffen HM
    Ann Intern Med; 2011 Sep; 155(6):405-7. PubMed ID: 21930865
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
    Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
    Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypocalcemic tetany following the administration of phosphate enema].
    Franch F; Verd F; Hernandez P; Xamena M; Díaz A
    Rev Esp Anestesiol Reanim; 1995 Jan; 42(1):35-6. PubMed ID: 7892532
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis.
    Adams JP; Conway SP; Wilson C
    Respir Med; 1998 Mar; 92(3):602-4. PubMed ID: 9692133
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma.
    Mune T; Yasuda K; Ishii M; Matsunaga T; Miura K
    Intern Med; 1993 May; 32(5):434-7. PubMed ID: 8400511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetany following phosphate enemas in chronic renal disease.
    Chesney RW; Haughton PB
    Am J Dis Child; 1974 Apr; 127(4):584-6. PubMed ID: 4821324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.